Category: Lab Management

Lab Management

ADLM announces new leadership appointments, with key changes to its board and executive roles.

A federal court ruled in favor of AMP, striking down the FDA’s attempt to regulate laboratory-developed tests (LDTs) as medical devices.

Xifin has added two major payors to its Payor Rate Transparency Monitor. Labs will now have even more data to help with reimbursements.

COLA Inc. is rebranding as the Commission on Laboratory Accreditation (COLA) to better reflect its mission promoting laboratory excellence.

Xifin’s CEO sees a window of opportunity for lawmakers to modify the Final Rule on LDTs that will be a win-win for the industry and patients.

Lot-to-lot reagent inconsistencies can have significant effects on patient test results.

SSI Diagnostica Group is acquiring Gulf Coast Scientific to expand its gastrointestinal disease testing capabilities.

ADLM 2025 study finds people in high-exposure areas are more than twice as likely to have elevated PFAS concentrations.